US FDA's Abernethy 'Cautious' About Real-World Evidence

 
• By Derrick Gingery
FDA Principle Deputy Commissioner Amy Abernethy speaking to a Pharmaceutical Research and Manufacturers of America conference
US FDA Principal Deputy Commissioner Amy Abernethy said companies must "pressure test" RWE ideas to prove their viability. • Source: Derrick Gingery

More from Real-World Evidence

More from Clinical Trials